Načítá se...
Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
HIV-1 integrase is the third enzymatic target of antiretroviral (ARV) therapy. However, few data have been published on the distribution of naturally occurring amino acid variation in this enzyme. We therefore characterized the distribution of integrase variants among more than 1,800 published group...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2546438/ https://ncbi.nlm.nih.gov/pubmed/18687142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-5-74 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|